These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11535312)

  • 1. Measles seroepidemiology and decay rate of vaccine-induced measles IgG titers in Taiwan, 1995-1997.
    Lee MS; Chien LJ; Yueh YY; Lu CF
    Vaccine; 2001 Sep; 19(32):4644-51. PubMed ID: 11535312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles IgG seroprevalence prior to mass vaccination in Taiwan.
    Lee MS; Nokes DJ; Wu YC; Huang YH; Lu CF
    Int J Infect Dis; 2002 Mar; 6(1):42-7. PubMed ID: 12044301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting and comparing long-term measles antibody profiles of different immunization policies.
    Lee MS; Nokes DJ
    Bull World Health Organ; 2001; 79(7):615-24. PubMed ID: 11477964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral and cellular immune response after measles vaccination in Taiwan.
    Huang CL; Yang YH; Wang LC; Lin YT; Tsai YY; Chiang BL
    J Microbiol Immunol Infect; 2005 Jun; 38(3):169-75. PubMed ID: 15986066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles immunity and response to revaccination among secondary school children in Cumbria.
    Calvert N; Cutts F; Irving R; Brown D; Marsh J; Miller E
    Epidemiol Infect; 1996 Feb; 116(1):65-70. PubMed ID: 8626005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of measles antibodies before and after vaccination in previously unvaccinated children of the Cordillera Province (Santa Cruz Department, Bolivia).
    Guglielmetti P; Bianchi Bandinelli ML; Bartoloni A; Gamboa H; Roselli M; Valensin PE
    J Trop Med Hyg; 1994 Aug; 97(4):231-5. PubMed ID: 8064946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles seroepidemiology among adolescents and young adults: response to revaccination.
    Saffar MJ; Alraza-Amiri M; Ajami A; Baba-Mahmoodi F; Khalilian AR; Vahidshahi C; Shamsizadeh A
    East Mediterr Health J; 2006 Sep; 12(5):573-81. PubMed ID: 17333796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles epidemics and seroepidemiology of population in Wujin, Changzhou city, Jiangsu province, China 2015.
    Tang L; Zhou Y; Pan Y; Zhu H
    Vaccine; 2017 May; 35(22):2925-2929. PubMed ID: 28433329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
    J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
    Kremer JR; Schneider F; Muller CP
    Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Declining measles antibodies in the era of elimination: Australia's experience.
    Gidding HF; Quinn HE; Hueston L; Dwyer DE; McIntyre PB
    Vaccine; 2018 Jan; 36(4):507-513. PubMed ID: 29269156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles virus-specific antibody levels in individuals in Argentina who received a one-dose vaccine.
    Argüelles MH; Orellana ML; Castello AA; Villegas GA; Masini M; Belizan AL; González Ayala S; Vera OD; Glikmann G
    J Clin Microbiol; 2006 Aug; 44(8):2733-8. PubMed ID: 16891485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective titres of measles neutralising antibody.
    Lee MS; Nokes DJ; Hsu HM; Lu CF
    J Med Virol; 2000 Dec; 62(4):511-7. PubMed ID: 11074481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum anti-tetanus and measles antibody titres in Ugandan children aged 4 months to 6 years: implications for vaccine programme.
    Warrener L; Bwogi J; Andrews N; Samuel D; Kabaliisa T; Bukenya H; Brown K; Roper MH; Featherstone DA; Brown D
    Epidemiol Infect; 2018 Jul; 146(9):1151-1156. PubMed ID: 29739482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
    Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
    Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age.
    Paunio M; Hedman K; Davidkin I; Valle M; Heinonen OP; Leinikki P; Salmi A; Peltola H
    Epidemiol Infect; 2000 Apr; 124(2):263-71. PubMed ID: 10813152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination.
    Cohen BJ; Doblas D; Andrews N
    Vaccine; 2008 Nov; 26(50):6392-7. PubMed ID: 18834911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 2001 serological survey in the Czech Republic--measles.
    Mrázová M; Svandová E; Smelhausová M; Sestáková Z; Benes C
    Cent Eur J Public Health; 2003 Dec; 11 Suppl():S36-41. PubMed ID: 15080258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroepidemiology for measles among elementary school children in Northern Taiwan.
    Lin YC; Hsieh YC; Huang YL; Huang YC; Hung YT; Huang YC
    J Microbiol Immunol Infect; 2016 Aug; 49(4):561-6. PubMed ID: 25442863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.